Summary:
A randomized, double-blind, placebo-controlled, multicenter trial with an enriched study design to assess the efficacy and safety of oxycodone/naloxone controlled-release tablets (oxn) compared to placebo in opioid-experienced subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy.
Qualified Participants Must:
• Be at least 18 years of age
•
Be currently taking a stable dose of an opiod medication equivalent to 20 - 120 mg of morphine
Qualified Participants May Receive:
Study related medical care, study medication or placebo, and compensation up to $450.